Cargando…
Antimalarials – old drugs are new again
The aim of this study was to discuss the therapeutic mechanism of action of antimalarials, in particular hydroxychloroquine (HCQ), in patients with lupus erythematosus. It examines the results of recent studies indicating the need to revise the indications, dosage and duration of safe therapy, thus...
Autor principal: | Woźniacka, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131958/ https://www.ncbi.nlm.nih.gov/pubmed/35645661 http://dx.doi.org/10.5114/ada.2021.108423 |
Ejemplares similares
-
How old is too old to work for physicians?
por: Kimak, Agnieszka, et al.
Publicado: (2023) -
AMPylation: Something Old is New Again
por: Woolery, Andrew R., et al.
Publicado: (2010) -
What’s old is new again: Insights into diabetic foot microbiome
por: Rajab, Azza A H, et al.
Publicado: (2023) -
The genomic architecture of antimalarial drug resistance
por: Cowell, Annie N, et al.
Publicado: (2019) -
Antimalarial Drug Resistance and Novel Targets for Antimalarial Drug Discovery
por: Shibeshi, Melkamu Adigo, et al.
Publicado: (2020)